Marksans Pharma

{
  "main_header": {
    "sid": 604869,
    "name": "Marksans Pharma",
    "stock_name": "Marksans Pharma",
    "full_name": "Marksans Pharma Ltd",
    "name_url": "stocks-analysis/marksans-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "265.30",
    "chg": -0.65,
    "chgp": "-0.24%",
    "dir": -1,
    "prev_price": "265.95",
    "mcapval": "12,022.43 Cr",
    "mcap": "Small Cap",
    "scripcode": 524404,
    "symbol": "MARKSANS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE750C01026",
    "curr_date": "Jun 24, 02:25 PM",
    "curr_time": "14:26 PM",
    "last_traded_at": "Jun 24, 02:25 PM IST",
    "bse_nse_vol": "33.65 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 275",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-new-52-week-high-of-rs275-on-24-june-2026-4069987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_priceRelatedfactors_4069987.png",
        "date": "2026-06-24 09:42:56",
        "description": "With a decisive surge to Rs 275 on 24 Jun 2026, Marksans Pharma Ltd has reached a fresh 52-week high, extending its recent momentum amid a broadly supportive market backdrop."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 268.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-new-52-week-high-of-rs26895-on-23-june-2026-4068624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_priceRelatedfactors_4068624.png",
        "date": "2026-06-23 09:47:34",
        "description": "With a decisive surge to Rs 268.95 on 23 Jun 2026, Marksans Pharma Ltd has reached a fresh 52-week high, extending its year-long rally that has outpaced the broader market by over 16 percentage points."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-buy-by-marketsmojo-4065069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_mojoScore_4065069.png",
        "date": "2026-06-20 10:10:29",
        "description": "Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Marksans Pharma Ltd Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-valuation-shifts-signal-changing-price-attractiveness-4062563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_valuationdot_4062563.png",
        "date": "2026-06-19 08:00:34",
        "description": "Marksans Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that significantly outpace the broader market. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors."
      },
      {
        "title": "Marksans Pharma Gains 8.22%: Key Financial and Technical Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-822-key-financial-and-technical-drivers-behind-the-rally-4051396",
        "imagepath": "",
        "date": "2026-06-13 13:02:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock opens at Rs.236.05, up 1.31% despite Sensex decline</p>\n                    <p><strong>9 June:</strong> Intraday high of Rs.252.40 with 7.22% surge; upgraded to Buy rating</p>\n                    <p><strong>10 June:</strong> Reports record quarterly performance; stock dips 2.22%</p>\n                    <p><strong>11 June:</strong> Modest recovery with 1.07% gain</p>\n                    <p><strong>12 June:</strong> Week closes at Rs.252.15, up 1.00% on strong Sensex rally</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.233.00</div><..."
      },
      {
        "title": "Marksans Pharma Ltd Reports Record Quarterly Performance Amid Flat Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-reports-record-quarterly-performance-amid-flat-financial-trend-4044318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_fintrenddot_4044318.png",
        "date": "2026-06-10 15:00:25",
        "description": "Marksans Pharma Ltd has delivered its strongest quarterly results to date in March 2026, posting record net sales and profitability metrics despite a shift in its financial trend from positive to flat. The pharmaceutical company’s latest performance highlights robust operational execution, though recent market sentiment has tempered its mojo grade to Hold from Buy."
      },
      {
        "title": "Marksans Pharma Ltd Surges 7.22% to Day's High of Rs 252.4 — Outperforms Sector by 6.02 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-intraday-high-with-722-surge-on-9-june-2026-4041320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_priceRelatedfactors_4041320.png",
        "date": "2026-06-09 15:16:25",
        "description": "The Sensex edged up 0.55% on 09 Jun 2026, yet Marksans Pharma Ltd outpaced the broader market with a robust 7.22% gain, reaching an intraday high of Rs 252.4. This 6.02 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Marksans Pharma Ltd Upgraded to Buy on Strong Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-upgraded-to-buy-on-strong-financial-and-technical-metrics-4040545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_mojoScore_4040545.png",
        "date": "2026-06-09 08:58:18",
        "description": "Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly performance, improved management efficiency, and attractive valuation relative to its peers within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Marksans Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-hold-by-marketsmojo-4037041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MarksansPharmaL_mojoScore_4037041.png",
        "date": "2026-06-08 10:10:40",
        "description": "Marksans Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 383,
    "sid": "604869",
    "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Updates",
      "datetime": "16-Jun-2026",
      "details": "Update on acquisition of QliniQ B.V.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "09-Jun-2026",
      "details": "India Ratings and Research has revised the outlook for the Companys bank loan facilities to Positive from Stable",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Jun-2026",
      "details": "Intimation of schedule for Virtual Investors Conference",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25",
          "dt": "2025-08-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 275

2026-06-24 09:42:56

With a decisive surge to Rs 275 on 24 Jun 2026, Marksans Pharma Ltd has reached a fresh 52-week high, extending its recent momentum amid a broadly supportive market backdrop.

Read full news article

Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 268.95

2026-06-23 09:47:34

With a decisive surge to Rs 268.95 on 23 Jun 2026, Marksans Pharma Ltd has reached a fresh 52-week high, extending its year-long rally that has outpaced the broader market by over 16 percentage points.

Read full news article

Marksans Pharma Ltd is Rated Buy by MarketsMOJO

2026-06-20 10:10:29

Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, returns, and overall outlook.

Read full news article

Marksans Pharma Ltd Valuation Shifts Signal Changing Price Attractiveness

2026-06-19 08:00:34

Marksans Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite delivering robust returns that significantly outpace the broader market. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors.

Read full news article

Marksans Pharma Gains 8.22%: Key Financial and Technical Drivers Behind the Rally

2026-06-13 13:02:31

Key Events This Week

8 June: Stock opens at Rs.236.05, up 1.31% despite Sensex decline

9 June: Intraday high of Rs.252.40 with 7.22% surge; upgraded to Buy rating

10 June: Reports record quarterly performance; stock dips 2.22%

11 June: Modest recovery with 1.07% gain

12 June: Week closes at Rs.252.15, up 1.00% on strong Sensex rally

Week Open

Rs.233.00

<...

Read full news article

Marksans Pharma Ltd Reports Record Quarterly Performance Amid Flat Financial Trend

2026-06-10 15:00:25

Marksans Pharma Ltd has delivered its strongest quarterly results to date in March 2026, posting record net sales and profitability metrics despite a shift in its financial trend from positive to flat. The pharmaceutical company’s latest performance highlights robust operational execution, though recent market sentiment has tempered its mojo grade to Hold from Buy.

Read full news article

Marksans Pharma Ltd Surges 7.22% to Day's High of Rs 252.4 — Outperforms Sector by 6.02 Percentage Points

2026-06-09 15:16:25

The Sensex edged up 0.55% on 09 Jun 2026, yet Marksans Pharma Ltd outpaced the broader market with a robust 7.22% gain, reaching an intraday high of Rs 252.4. This 6.02 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Marksans Pharma Ltd Upgraded to Buy on Strong Financial and Technical Metrics

2026-06-09 08:58:18

Marksans Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly performance, improved management efficiency, and attractive valuation relative to its peers within the Pharmaceuticals & Biotechnology sector.

Read full news article

Marksans Pharma Ltd is Rated Hold by MarketsMOJO

2026-06-08 10:10:40

Marksans Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News